At Celgene we believe that a commitment to medical progress achieved through innovative science and life-enhancing new therapies must go hand in hand with a corresponding promise to ensure that patients who can benefit from our discoveries have the opportunity to do so.
dverse events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk. Adverse events should also be reported to Celgene Drug Safety (Tel: 0808 238 9908; Fax: 0844 801 0468).
To contact Celgene in the UK for medical information and product supply enquiries, please telephone or e-mail the medical information department using the contact details below.
Tel: +44 (0) 844 801 0045
Fax: +44 (0) 844 801 0046